CSI Market
Sign In | Register

Acadia Pharmaceuticals Inc (ACAD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ACAD Annual Balance Sheets →
This balance sheet overview for Acadia Pharmaceuticals Inc spans from Sep 30 2025 to Sep 30 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ACAD/balance-sheets
https://api.csimarket.com/api/v1/companies/ACAD/fundamentals
https://api.csimarket.com/api/v1/companies/ACAD/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent322.37
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments322.00
Accounts receivable161.02
Interest Receivable, Current17.30
Inventories106.84
Prepaid Expense, Current AS73.31
Total Current Assets1,268.43
Equipment/Property/Plant Net18.40
Intangible Assets135.48
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent959.44
Short Term Inventory31.57
Deferred Income Tax Assets Net249.62
Operating Lease Right Of Use Asset46.27
Restricted Cash Noncurrent7.85
Total Assets1,794.15
Liabilities
Accounts Payable, Current AC16.33
Accrued Liabilities, Current AC315.89
Taxes Payable0.00
Total Current Liabilities332.22
Total Long-term Debt0.00
Other liabilities, Noncurrent74.45
Operating Lease Liability Noncurrent39.00
Total Liabilities406.66
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock3,115.14
Retained Earnings / Accumulated Deficit-1,724.73
Accumulated Other Comprehensive Income-2.94
Other Equity-2.94
Common Stockholder's Equity1,387.49
Total Stockholder's Equity1,387.49
Liabilities & Stockholder's Equity1,794.15
4 historic quarters locked

Sign in to unlock the full Acadia Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Acadia Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-447794

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI